AVANOS MEDICAL, INC. AVNS Income Statement

Avanos medical, inc. (AVNS)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Sep'13
Net Sales
180,400	189,800	171,400	172,200	164,200	169,900	165,100	160,900	156,400	166,300	150,500	149,100	145,700	-616,100	397,500	400,000	384,800	-664,000	389,500	389,300	394,200	439,400	408,500	413,500	410,700	419,500
Cost of products sold
78,300	80,100	76,400	73,500	65,400	69,500	60,400	66,200	65,300	76,400	69,500	64,600	64,200	-498,100	259,500	259,300	248,300	-523,800	258,500	254,400	262,100	282,900	276,300	308,600	255,700	258,000
Gross Profit
102,100	109,700	95,000	98,700	98,800	100,400	104,700	94,700	91,100	89,900	81,000	84,500	81,500	-118,000	138,000	140,700	136,500	-140,200	131,000	134,900	132,100	156,500	132,200	104,900	155,000	161,500
Research and development
9,400	8,400	9,600	9,500	10,200	10,600	10,500	10,800	9,900	12,100	9,600	9,200	7,300	9,300	10,900	9,500	8,700	5,100	10,200	6,300	6,000	7,500	8,500	9,300	8,300	8,900
Selling and general expenses
91,100	103,600	94,400	94,700	106,400	87,900	86,300	79,800	86,400	77,400	78,400	81,100	84,800	45,200	100,300	107,900	92,800	49,500	97,200	105,800	97,200	126,400	111,300	101,300	85,500	82,500
Goodwill impairment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	475,500	-	-	-	0	-	-	-
Other expense, net
-1,000	-900	-9,100	-4,300	-6,800	-10,200	-900	4,700	-1,800	-3,400	-3,400	-6,300	-7,000	-6,200	-5,900	-5,700	-1,900	-18,200	-9,300	-700	12,000	1,400	700	1,200	500	200
Operating Income (Loss)
600	-3,200	-18,100	-9,800	-24,600	-8,300	7,000	8,800	-7,000	-3,000	-10,400	-12,100	-17,600	-178,700	20,900	17,600	33,100	262,500	-461,200	22,100	40,900	24,000	13,100	-4,500	61,700	70,300
Interest income
700	1,000	1,300	2,000	2,400	2,400	2,200	2,200	1,000	900	700	500	400	100	200	100	200	100	0	100	100	0	1,000	900	1,000	700
Interest expense
4,300	4,300	3,500	3,500	3,700	3,500	4,200	9,900	8,800	8,100	8,100	7,800	7,600	8,000	8,400	8,300	8,000	8,100	7,800	8,900	8,300	5,900	100	0	0	0
Loss Before Income Taxes
-3,000	-6,500	-20,300	-11,300	-25,900	-9,400	5,000	1,100	-14,800	-10,200	-17,800	-19,400	-24,800	-186,600	12,700	9,400	25,300	254,500	-469,000	13,300	32,700	18,100	14,000	-3,600	62,700	71,000
Income tax benefit
-6,700	-400	-8,800	-3,300	-5,600	-6,700	800	-200	-3,500	-14,600	-7,600	-8,000	-9,900	-73,500	3,600	2,900	11,100	-85,100	1,500	5,300	11,000	20,500	21,400	900	21,300	23,100
Loss from Continuing Operations
-	-	-11,500	-8,000	-	-2,700	4,200	1,300	-11,300	4,400	-10,200	-11,400	-14,900	-	-	-	-	-	-	-	-	-	-	-	-	-
Income from discontinued operations, net of tax
-	-	0	0	-	500	0	34,000	31,500	28,400	26,800	28,500	27,700	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income (Loss)
3,700	-6,100	-11,500	-8,000	-20,300	-2,200	4,200	35,300	20,200	32,800	16,600	17,100	12,800	10,000	9,100	6,500	14,200	14,500	-470,500	8,000	21,700	-2,400	-7,400	-4,500	41,400	47,900
Earnings (Loss) Per Share
Basic:
Continuing operations (in dollars per share)
-	-	-0.24	-0.17	-	-0.06	0.09	0.03	-0.24	0.09	-0.22	-0.24	-0.32	-	-	-	-	-	-	-	-	-	-	-	-	-
Discontinued operations (in dollars per share)
-	-	0.00	0.00	-	0.01	0.00	0.72	0.67	0.61	0.57	0.61	0.59	-	-	-	-	-	-	-	-	-	-	-	-	-
Basic (in dollars per share)
0.08	-0.12	-0.24	-0.17	-0.43	-0.05	0.09	0.75	0.43	0.70	0.35	0.37	0.27	0.22	0.19	0.14	0.30	0.31	-10.10	0.17	0.47	-0.05	-0.16	-0.10	0.89	-
Diluted:
Continuing operations (in dollars per share)
-	-	-0.24	-0.17	-	-0.06	0.09	0.03	-0.24	0.09	-0.22	-0.24	-0.32	-	-	-	-	-	-	-	-	-	-	-	-	-
Discontinued operations (in dollars per share)
-	-	0.00	0.00	-	0.03	0.00	0.70	0.67	0.61	0.57	0.61	0.59	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted (in earnings per share)
0.08	-0.12	-0.24	-0.17	-0.43	-0.03	0.09	0.73	0.43	0.70	0.35	0.37	0.27	0.22	0.19	0.14	0.30	0.32	-10.10	0.17	0.46	-0.05	-0.16	-0.10	0.89	-